Costing infectious disease outbreaks for economic evaluation: A review for hepatitis a

PharmacoEconomics

Volumn 27, Issue 5, 2009, Pages 379-389

  Luyten, Jeroen ^a   Beutels, Philippe ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

CANADA; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ECONOMIC EVALUATION; EPIDEMIC; FOOD CONTAMINATION; HEPATITIS A; HOMOSEXUALITY; HUMAN; INCIDENCE; ITALY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SCHOOL; UNITED KINGDOM; UNITED STATES; URBAN AREA; VACCINATION;

ADULT; CHILD; COMMUNICABLE DISEASE CONTROL; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; FOOD CONTAMINATION; HEALTH CARE COSTS; HEPATITIS A; HOMOSEXUALITY, MALE; HUMANS; MALE; NEEDLE SHARING; SCHOOLS;

EID: 67749122665     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/00019053-200927050-00003     Document Type: Review

References (33)

1. Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004; 350 (5): 476-81
2. Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109 (5): 839-45
3. Hendrickx G, Van Herck K, Vorsters A, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 2008 Oct; 15 Suppl. 2: 1-15
4. Dalton CB, Haddix A, Hoffman RE, et al. The cost of a food-borne outbreak of hepatitis A in Denver, Colo. Arch Intern Med 1996; 156 (9): 1013-6
5. Bownds L, Lindekugel R, Stepak P. Economic impact of a hepatitis A epidemic in a mid-sized urban community: the case of Spokane, Washington. J Community Health 2003; 28 (4): 233-46
6. Sansom SL, Cotter SM, Smith F, et al. Costs of a hepatitis A outbreak affecting homosexual men: Franklin County, Ohio, 1999. Am J Prev Med 2003; 25 (4): 343-6
7. Demicheli V, Rivetti D, Jefferson TO. Economic aspects of a small epidemic of hepatitis A in a religious community in Northern Italy. J Infect 1996; 33 (2): 87-90
8. Lucioni C, Cipriani V, Mazzi S, et al. Cost of an outbreak of hepatitis A in Puglia, Italy. Pharmacoeconomics 1998; 13 (2): 257-66
9. Taylor-Robinson DC, Regan M, Crowcroft N, et al. Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom. Euro Surveill 2007; 12 (12): E5-6
10. Tricco AC, Pham B, Duval B, et al. Areview of interventions triggered by hepatitis A infected food-handlers in Canada. BMC Health Serv Res 2006; 6: 157
11. Howitz MF, Mazick A, Cowan SA, et al. The economic impact of an epidemic of hepatitis A among men who have sex with men [in Danish]. Ugeskr Laeger 2007; 169 (41): 3489-92
12. Beutels P, Edmunds WJ, Smith RD. Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. Health Econ 2008; 17 (11): 1317-22
13. Drummond M, O'Brien B, Stoddart G, et al. Methods for the economic evaluation of health care programmes. New York (NY): Oxford University Press, 1997
14. OECD. OECD health data statistics and indicators for 30 countries. 2007 ed [CD-rom]. Paris: OECD Publishing, 2007
15. United States Department of Labour, Bureau of Labour Statistics, consumer price index (All Urban Consumers) [online]. Available from URL: http://www.bls.gov/cpi/ #tables [Accessed 2008 Jul 15]
16. Bauch CT, Anonychuk AM, Pham BZ, et al. Cost-utility of universal hepatitis A vaccination in Canada. Vaccine 2007; 25 (51): 8536-48
17. Postma MJ, Bos JM, Beutels P, et al. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Vaccine 2004; 22 (15-16): 1862-7
18. Chodick G, Lerman Y, Wood F, et al. Cost-utility analysis of hepatitis A prevention among health-care workers in Israel. J Occup Environ Med 2002; 44 (2): 109-15
19. Egoz N. Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study. Isr J Med Sci 1986; 22 (3-4): 277-82
20. Patnaik JL, Dippold L, Vogt RL. Hepatitis A in a food worker and subsequent prophylaxis of restaurant patrons. J Environ Health 2006; 69 (1): 16-8, 24, 26
21. Todd EC. Costs of acute bacterial foodborne disease in Canada and the United States. Int J Food Microbiol 1989; 9 (4): 313-26
22. Berge JJ, Drennan DP, Jacobs RJ, et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000; 31 (2): 469-73
23. Tolsma DD, Bryan JA. The economic impact of viral hepatitis in the United States. Public Health Rep 1976; 91 (4): 349-53
24. Chossegros P, Chevallier P, Ritter J, et al. Cost of acute hepatitis A in adults in France [in French]. Presse Med 1994; 23 (12): 561-4
25. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral hepatitis and liver disease. Baltimore (MD): Williams and Wilkins, 1991: 14-9
26. de Juanes JR, Gonzalez A, Arrazola MP, et al. Cost analysis of two strategies for hepatitis A vaccination of hospital health-care personnel in an intermediate endemicity area. Vaccine 2001; 19 (30): 4130-4
27. Diel R, Rappenhoner B. The cost structure of illness due to hepatitis A in Germany. Eur J Health Econ 2000; 1: 20-5
28. Jacobs RJ, Margolis HS, Coleman PJ. The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates. Arch Pediatr Adolesc Med 2000; 154 (8): 763-70
29. Myers RP, Gregor JC, Marotta PJ. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 2000; 31 (4): 834-9
30. Pechevis M, Khoshnood B, Buteau L, et al. Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection. Vaccine 2003; 21 (25-26): 3556-64
31. Jacobs RJ, Greenberg DP, Koff RS, et al. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J 2003; 22 (10): 904-14
32. O'Connor JB, Imperiale TF, Singer ME. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults. Hepatology 1999; 30 (4): 1077-81
33. Smith S, Weber S, Wiblin T, et al. Cost-effectiveness of hepatitis A vaccination in healthcare workers. Infect Control Hosp Epidemiol 1997; 18 (10): 688-91